Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
Abstract The expanding targeted therapy landscape requires combinatorial biomarkers for patient stratification and treatment selection. This requires simultaneous exploration of multiple genes of relevant networks to account for the complexity of mechanisms that govern drug sensitivity and predict c...
Guardado en:
Autores principales: | Vladimir Lazar, Shai Magidi, Nicolas Girard, Alexia Savignoni, Jean-François Martini, Giorgio Massimini, Catherine Bresson, Raanan Berger, Amir Onn, Jacques Raynaud, Fanny Wunder, Ioana Berindan-Neagoe, Marina Sekacheva, Irene Braña, Josep Tabernero, Enriqueta Felip, Angel Porgador, Claudia Kleinman, Gerald Batist, Benjamin Solomon, Apostolia Maria Tsimberidou, Jean-Charles Soria, Eitan Rubin, Razelle Kurzrock, Richard L. Schilsky |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/03d1a19c53bf406b8f14275e04c89c95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be golden
por: Amélie Boichard, et al.
Publicado: (2021) -
Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects
por: Berindan-Neagoe I, et al.
Publicado: (2012) -
Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?
por: Tomuleasa C, et al.
Publicado: (2013) -
Nanopharmacology in translational hematology and oncology
por: Tomuleasa C, et al.
Publicado: (2014) -
MRI-based identification of undifferentiated cells: looking at the two faces of Janus
por: Tomuleasa C, et al.
Publicado: (2014)